SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,201.91 -507.78
( -0.69%)

Global Indices

Nasdaq

52,880.09 363.21
(0.69%)

Dow Jones

7,780.08 46.51
(0.60%)

Hang Seng

64,728.80 653.38
(1.02%)

Nikkei 225

10,751.68 18.68
(0.17%)

Forex

USD-INR

94.82 -0.08
(-0.09%)

EUR-INR

106.45 0.01
(0.01%)

GBP-INR

126.63 0.25
(0.20%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

91669

INE0PLZ01012

44.9147092

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNREST

4.86

15.02

EPS(TTM)

Face Value()

Div & Yield %

7.2

Back

Swan Corp reports consolidated net loss of Rs 31.42 crore in the June 2026 quarter

Aug 14,2026

Net loss of Swan Corp reported to Rs 31.42 crore in the quarter ended June 2026 as against net profit of Rs 19.13 crore during the previous quarter ended June 2025. Sales declined 16.44% to Rs 1013.75 crore in the quarter ended June 2026 as against Rs 1213.18 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1013.75	1213.18	-16
OPM %	-0.38	2.20	-
PBDT	-4.39	63.74	PL
PBT	-34.96	33.64	PL
NP	-31.42	19.13	PL

73,201.91 -507.78 ( -0.69%)

52,880.09 363.21 (0.69%)

7,780.08 46.51 (0.60%)

64,728.80 653.38 (1.02%)

10,751.68 18.68 (0.17%)

94.82 -0.08 (-0.09%)

106.45 0.01 (0.01%)

126.63 0.25 (0.20%)

0.60 0.00 (-0.04%)